JAMES HAWLEY: Open Payments
NPI 1275946162 · CENTREVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 8 payments from 7 companies in 2025. Trend: 2023 $171 · 2024 $352 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $67 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Tactile Systems Technology Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: RELISTOR, VERQUVO, Flexitouch Plus, CAPLYTA, JARDIANCE, OTEZLA.
Industry payments across MS — which companies pay providers there.
